Business
Merck drug less effective against moderate COVID -India regulatory source – Reuters
Merck & Co’s (MRK.N) experimental antiviral drug molnupiravir has not shown “significant efficacy” against moderate COVID-19,…
The Merck logo is seen at a gate to the Merck & Co campus in Rahway, New Jersey, U.S., July 12, 2018. REUTERS/Brendan McDermidNEW DELHI, Oct 8 (Reuters) – Merck & Co’s (MRK.N) experimental antiviral drug molnupiravir has not shown “significant efficacy”…
Continue Reading
-
General17 hours agoVictorian school teacher charged with soliciting child abuse material
-
General9 hours agoAustralia loses ODI series to South Africa with defeat in second game in Mackay
-
Business21 hours agoEconomic roundtable or maturity test?
-
General22 hours agoBackpackers threaten to leave town if Broome’s ‘bush doof’ crackdown continues